Gerhard Fischer

Gerhard Fischer has a rich work experience, starting from their role as a Teaching Assistant and Research Assistant at the University of Bonn from 2001 to 2006. Gerhard then moved on to the University of Gothenburg, where they first worked as a PhD student, specializing in biochemistry and focusing on the structure and function of Aqua(glycero)porins. Later, they served as a Postdoctoral Fellow at the same university, conducting structural studies on membrane proteins using X-Ray Diffraction. During this time, they obtained the world's best diffracting membrane protein crystal.

In 2011, Gerhard worked as a Senior Research Scientist at AstraZeneca R&D before becoming a Contractor at Proffice - Life Science. In 2012, they joined the University of Cambridge as a Postdoctoral Research Associate, specializing in structure-based drug design, cancer research, and fragment-based lead discovery. Gerhard also provided crystallography and IT expertise for various projects. Notably, they developed an automated pipeline for high-throughput protein crystallography and created strategies for data management and analysis.

Gerhard joined Boehringer Ingelheim in 2017 and has held various roles there. Their first role was as an Associate Principal Scientist, followed by a promotion to Principal Scientist. Currently, they are working as a Principal Scientist I at Boehringer Ingelheim.

Gerhard Fischer's education history begins with a MSc (Diplom Chemiker) in Chemistry from The University of Bonn, which they completed from 1999 to 2006. Gerhard then pursued a PhD in Biochemistry / Biophysics / Structural Biology from the University of Gothenburg, which they obtained from 2006 to 2011. After that, they conducted Postdoctoral Research in Structure based drug design at the University of Cambridge from 2012 to 2017. In addition, in 2012 to 2013, they studied Management of Innovation and Technology (MoTI) at the Cambridge Judge Business School.